Skip to main content
AHN-GOOK PHARMACEUTICAL Co., Ltd. logo

AHN-GOOK PHARMACEUTICAL Co., Ltd. — Investor Relations & Filings

Ticker · 001540 ISIN · KR7001540004 KO Manufacturing
Open in API
Filings indexed 170 across all filing types
Latest filing 2024-06-05 Major Shareholding Noti…
Country KR South Korea
Listing KO 001540

About AHN-GOOK PHARMACEUTICAL Co., Ltd.

https://www.no1health2.or.kr:19621/

AHN-GOOK PHARMACEUTICAL Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a broad range of medicines. The company has a strong focus on treatments for the respiratory system and cardiovascular diseases. Its product portfolio includes prescription drugs, over-the-counter medications, and health supplements, with notable products such as Synatura Syrup for respiratory conditions, as well as treatments for digestive and ophthalmic health. The company is dedicated to promoting human health and improving quality of life through the development of innovative and effective pharmaceutical solutions for a global market.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (insiders) and their special relations, including collateral agreements. This type of filing is classified as a Major Shareholding Notification (MRQ) in our taxonomy.
2024-06-05 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Ahn-Gook Pharmaceutical Co., Ltd. for the first quarter of 2024 (January 1, 2024, to March 31, 2024). It contains detailed financial statements, business overviews, management discussions, and operational data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
본점소재지변경
Regulatory Filings Classification · 1% confidence The document is a formal regulatory announcement regarding a change in the company's headquarters location (본점소재지변경). It provides details on the previous and new addresses, the reason for the change, and the effective date. Since this type of corporate administrative update does not fall into specific categories like financial reports, dividends, or director dealings, it is classified as a general regulatory filing.
2024-04-19 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM) for Ahn-Gook Pharmaceutical. It details the approval of financial statements, dividend declarations, director appointments, and other resolutions passed during the meeting held on March 28, 2024. This fits the definition of a Declaration of Voting Results (DVA).
2024-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of audit opinions, financial highlights (assets, liabilities, equity, profit/loss), and auditor information for the fiscal year. While it contains financial data, it is a standardized regulatory disclosure form used to announce the receipt and submission of the audit report to the exchange, rather than the full annual report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Ahn-Gook Pharmaceutical Co., Ltd. for the fiscal year 2023. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. While it contains financial statements, it is specifically presented as an audit report document rather than a full 10-K annual report, fitting the 'Audit Report / Information' category. FY 2023
2024-03-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.